Vivet Therapeutics

Developer of gene therapies for inherited metabolic diseases

placeParis, Ile De France, France calendar_todayFounded 2016 groups30 employees language vivet-therapeutics.com

Social engagement

Social engagement: 5.6K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Novartis Venture Fund, Columbus Venture Partners, Pfizer.

Investor typeCountShare
Venture capital660%
Private equity330%
Other / undisclosed110%

Recent activity

6 May 2026
Event
Annual Congress of the American Society of Gene & Cell Therapy (ASGCT)
7 Nov 2025
Event
Jefferies Global Healthcare Conference
15 Oct 2025
Event
ESGCT Sevilla
Coming soon